Study of SGN-40 in Patients With Relapsed Diffuse Large B-Cell Lymphoma

Clinical trial NCT00435916 · COMPLETED

Trial details

NCT number: NCT00435916
Sponsor: Seagen Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lymphoma, Large B-Cell, Diffuse Lymphoma, Non-Hodgkin

Start date: 2006-12-01
Primary completion: 2009-01-01
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.